期刊文献+

非小细胞肺癌ROS1融合基因与ERCC1和RRM1基因mRNA表达的关系 被引量:1

Relationships between ROS1 Fusion Gene and the mRNA Expression of ERCC1 and RRM1 Gene in Tissues of Non Small Cell Lung Cancer
下载PDF
导出
摘要 目的探讨ROS1融合基因与切除修复交叉互补基因1(excision repair cross-complementation group 1,ERCC1)和核苷酸还原酶亚单位M1(ribonucleotide reductase subunit M1,RRM1)mRNA在非小细胞肺癌(non-small cell lung cancer,NSCLC)组织中表达的关系。方法应用实时荧光定量PCR方法检测257例NSCLC中ROS1基因及ERCC1和RRM1基因mRNA的表达。结果 ROS1融合基因及ERCC1和RRM1基因mRNA的表达均与患者性别、年龄、是否吸烟、肿瘤大小、淋巴结是否转移及临床分期无关(P>0.05)。ROS1融合基因与ERCC1和RRM1基因mRNA表达水平无关,且ERCC1基因mRNA表达水平与RRM1基因mRNA表达水平无关(P>0.05)。结论 NSCLC组织中ROS1融合基因表达可能与ERCC1和RRM1基因表达无关。 Objective To explore relationships between ROS1 fusion gene,excision repair cross complement protein 1 gene(excision repair cross-complementation group 1,ERCC1)and nucleotide reductase subunits M1(ribonu-cleotide reductase subunit M1,RRM1)of mRNA expressions in tissues of non small cell lung cancer(NSCLC). Meth-ods Levels of ROS1 fusion gene and mRNA expressions of ERCC1 and RRM1 gene in 257 NSCLC patients were detected with real-time fluorescent quantitative PCR method. Results Levels of ROS1 fusion gene,and mRNA expressions of ERCC1 and RRM1 gene did not relate to gender,age,smoking history,tumor size,lymph node metastasis and clinical stage of patients(P〉0. 05);expression level of ROS1 fusion gene did not relate to mRNA expressions of ERCC1 and RRM1 gene,and the expression level of ERCC1 mRNA did not relate to the expression level of RRM1 mRNA( P 〉0. 05). Conclusion Expression of ROS1 fusion gene in tissues of non small cell lung cancer may not relate to the ER-CC1 and RRM1 expressions.
出处 《解放军医药杂志》 CAS 2014年第9期1-4,共4页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
基金 吴阶平医学基金会临床科研专项资助基金项目(320.6750.1360)
关键词 非小细胞肺 ROS1 切除修复交叉互补基因1 核苷酸还原酶亚单位 M1 Carcinoma, non-small-cell lung ROS1 Excision repair cross-complementation group 1 Ribonu- cleotide reductase subunit M1
  • 相关文献

参考文献26

  • 1Siegel R, Ma J, Zou Z, et al. Cancer Statistics, 2014 [J]. CA Cancer J Clin, 2014,64(1):9-29.
  • 2Sher T, Dy G K, Adjei A A. Small cell lung cancer[J]. Mayo Clin Proc, 2008,83(3) :355-367.
  • 3姜北,李晶,巩平.非小细胞肺癌患者血清EGFR基因突变循环DNA检测[J].中华肿瘤防治杂志,2014,21(1):29-33. 被引量:24
  • 4张建海,张艳丽.PTEN与非小细胞肺癌临床病理特征及预后的相关性[J].中国医药导报,2013,10(1):98-100. 被引量:10
  • 5Mok T S, Wu Y L, Thongprasert S, et al. Gefitinib or carboplatin- paclitaxel in pulmonary adenocarcinoma[J]. N Engl J Med, 2009,361 (10) :947-957.
  • 6Olaussen K A, Dunant A, Fouret P, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin- based adjuvant chemotherapy [ J ]. N Engl J Med, 2006, 355(10) :983-991.
  • 7Bepler G, Kusmartseva I, Sharma S, et al. RRM1 modu- lated in vitro and in vivo efficacy of gemcitabine and plati- num in non-small-cell lung cancer [ J ]. J Clin Oncol, 2006,24(29) :4731-4737.
  • 8胡赛男,冯继锋,吴建中,高长明,史美祺.RRM1基因多态性与非小细胞肺癌患者血清铂类化疗敏感的相关性分析[J].中华肿瘤防治杂志,2009,16(19):1477-1481. 被引量:1
  • 9Ou S H, Tan J, Yen Y, et al. ROS1 as a druggable'receptor tyrosine kinase: lessons learned from inhibiting the ALK pathway[J]. Expert Rev Anticancer Ther, 2012,12 (4) :447-456.
  • 10Acquaviva J, Wong R, Charest A. The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer[J]. Biochim Biophys Aeta, 2009,1795 ( 1 ) : 37- 52.

二级参考文献67

  • 1刘玉环,王锡智,蔡在龙,俞超芹,崔英,沙金燕.PTEN基因突变与遗传性癌症综合征及其相关疾病的研究进展[J].第二军医大学学报,2005,26(1):90-92. 被引量:5
  • 2李英红,徐春林,李慧慧.PTEN在非小细胞肺癌中的表达及其临床意义[J].哈尔滨医科大学学报,2006,40(5):394-396. 被引量:7
  • 3Bepler G, Zheng Z, Gautam A, et al. Ribonucleotide reduetase M1 gene promoter activity, polymorphisms,population frequencies, and clinical relevance[J]. Lung Cancer, 2005,47 (2) : 183- 192.
  • 4Rabik C A, Dolan M E. Molecular mechanisms of resistance and toxicity associated with platinating agents [J]. Cancer Treat Rev, 2007,33(1) :9-23.
  • 5Martin L P, Hamilton T C, Schilder R J. Platinum resistance:the role of DNA repair pathways[J]. Clin Cancer Res, 2008, 14(5):1291-1295.
  • 6Rosell R,Lord R V, Taron M, et al. DNA repair and cisplatin resistance in non-small-cell lung cancer[J]. Lung Cancer,2002, 38(3) :217- 227.
  • 7Campelo R G, Curbera G A, Aparicio M A, et al.GA Pharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum based chemotherapy [J]. Expert Opin Pharmaeother, 2005, 6(12):2015-2026.
  • 8Pitterle D M, Kim Y C, Joljcoeur E M, et al. Lung cancer and the human gene for Ribonucleotide reductase M1 (RRM1) [J]. Mamm Genome, 1999,10(9): 916-922.
  • 9Zhou B, Lin X, Mo X et al. The human ribonucleotide reducase subunit hRRM2 complements p53R2 in response to UV induced DNA repair in ceils with mutant p53 [J]. Cancer Res, 2003, 63 (20) : 6583-6594.
  • 10Gautam A, Li Z R, Bepler G. RRM1 induced metastasis sup pression through PTEN- regulated pathways[J]. Oncogene, 2003, 22(14):2135-2142.

共引文献48

同被引文献5

引证文献1

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部